Passive Equities

First Trust Nasdaq Pharmaceuticals ETF

The First Trust Nasdaq Pharmaceuticals ETF (the “Fund”) seeks investment results that correspond generally to the price and yield (before the Fund’s fees and expenses) of an equity index called the Nasdaq US Smart PharmaceuticalsTM Index (the “Index”).

$24.83

Compare similar ETFs

Fund Size
Dividend
Fees
Current
Nasdaq Pharmaceuticals ETF FTXH
Fund Size
$14.8 Million
Dividend
2.0%
Fees
0.60%
Total Stock Market Index Fund VTI
Fund Size
$1.78 Trillion
Dividend
1.3%
Fees
0.03%
500 Index Fund VOO
Fund Size
$1.35 Trillion
Dividend
1.3%
Fees
0.03%
Core S&P 500 ETF IVV
Fund Size
$590 Billion
Dividend
1.4%
Fees
0.03%
Total International Stock Index Fund VXUS
Fund Size
$447 Billion
Dividend
3.0%
Fees
0.07%
View 1303 similar ETFs →

Average metrics of all companies in portfolio

Compare to
Market
Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares. $129 Billion
Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price. 2.51 %
Beta Indicates the relationship between the price performance of a share and the market. 0.6494
P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth. 47.59
Negative P/E Ratio a negative P/E ratio shows that the company is not profitable, and it shows how many years it would take the company to lose its entire market capitalisation if it did not change anything -127.4
Profitable Companies 79
PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued. 94.07
Price to Sales Ratio Market cap divided by the revenue in the most recent year. 5.0
Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company 19.61
Compare to
Market
Enterprise Value to EBIT Enterprise Value divided by EBIT -91.36
Enterprise Value to Revenue Enterprise value divided by revenue 32.41
Total Debt to Enterprise Value Total debt divided by enterprise value 0.15
Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary. 2.7107
Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability. -58.71%
Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago. -
Return on Equity Equity divided by market cap. 5924.70%
Return on Assets Indicates a company's profitability in relation to its total assets. 294.41%
Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits. 427.06%

Industries

Healthcare 90.2%
Other 3.9%
Finance 2.0%
Industrials 2.0%
N/A 2.0%

Market cap

Micro Cap 2%
Small Cap 1%
Mid Cap 23%
Large Cap 50%
Mega Cap 24%

51 Investments

P/E-Ratio
Total Investment
Weight
Bristol-Myers Squibb Co logo

BMY - Manufacturing

Bristol-Myers Squibb Co

P/E-Ratio
-16.7
Total Investment
$1.32 Million
Weight
8.9%
Pfizer Inc logo

PFE - Manufacturing

Pfizer Inc

P/E-Ratio
16.2
Total Investment
$1.07 Million
Weight
7.2%
AbbVie Inc logo

ABBV - Manufacturing

AbbVie Inc

P/E-Ratio
78.0
Total Investment
$1.06 Million
Weight
7.1%
Johnson & Johnson logo

JNJ - Manufacturing

Johnson & Johnson

P/E-Ratio
17.0
Total Investment
$1.02 Million
Weight
6.9%
Merck & Co Inc logo

MRK - Manufacturing

Merck & Co Inc

P/E-Ratio
11.0
Total Investment
$980 Thousand
Weight
6.6%
Gilead Sciences Inc logo

GILD - Manufacturing

Gilead Sciences Inc

P/E-Ratio
20.2
Total Investment
$682 Thousand
Weight
4.6%
Cardinal Health Inc logo

CAH - Wholesale Trade

Cardinal Health Inc

P/E-Ratio
22.8
Total Investment
$612 Thousand
Weight
4.1%
Viatris Inc logo

VTRS - Finance and Insurance

Viatris Inc

P/E-Ratio
-16.5
Total Investment
$601 Thousand
Weight
4.1%
United Therapeutics Corp logo

UTHR - Manufacturing

United Therapeutics Corp

P/E-Ratio
11.2
Total Investment
$547 Thousand
Weight
3.7%
Jazz Pharmaceuticals PLC logo

JAZZ - Manufacturing

Jazz Pharmaceuticals PLC

P/E-Ratio
10.6
Total Investment
$526 Thousand
Weight
3.5%
Zoetis Inc logo

ZTS - Manufacturing

Zoetis Inc

P/E-Ratio
28.9
Total Investment
$518 Thousand
Weight
3.5%
Eli Lilly & Co logo

LLY - Manufacturing

Eli Lilly & Co

P/E-Ratio
59.4
Total Investment
$469 Thousand
Weight
3.2%
Amgen Inc logo

AMGN - Manufacturing

Amgen Inc

P/E-Ratio
24.1
Total Investment
$456 Thousand
Weight
3.1%
Biogen Inc logo

BIIB - Manufacturing

Biogen Inc

P/E-Ratio
11.7
Total Investment
$436 Thousand
Weight
2.9%
Organon & Co logo

OGN - Manufacturing

Organon & Co

P/E-Ratio
3.0
Total Investment
$364 Thousand
Weight
2.5%
Charles River Laboratories Int logo

CRL - Professional, Scientific, and Technical Services

Charles River Laboratories Int

P/E-Ratio
564.1
Total Investment
$356 Thousand
Weight
2.4%
Regeneron Pharmaceuticals Inc logo

REGN - Manufacturing

Regeneron Pharmaceuticals Inc

P/E-Ratio
12.5
Total Investment
$350 Thousand
Weight
2.4%
Medpace Holdings Inc logo

MEDP - Professional, Scientific, and Technical Services

Medpace Holdings Inc

P/E-Ratio
21.6
Total Investment
$273 Thousand
Weight
1.8%
Elanco Animal Health Inc logo

ELAN - Manufacturing

Elanco Animal Health Inc

P/E-Ratio
17.5
Total Investment
$243 Thousand
Weight
1.6%
Neurocrine Biosciences Inc logo

NBIX - Manufacturing

Neurocrine Biosciences Inc

P/E-Ratio
37.7
Total Investment
$237 Thousand
Weight
1.6%
Alkermes PLC logo

ALKS - Manufacturing

Alkermes PLC

P/E-Ratio
14.0
Total Investment
$166 Thousand
Weight
1.1%
Exelixis Inc logo

EXEL - Professional, Scientific, and Technical Services

Exelixis Inc

P/E-Ratio
19.7
Total Investment
$164 Thousand
Weight
1.1%
Halozyme Therapeutics Inc logo

HALO - Manufacturing

Halozyme Therapeutics Inc

P/E-Ratio
18.7
Total Investment
$162 Thousand
Weight
1.1%
Perrigo Co PLC logo

PRGO - Manufacturing

Perrigo Co PLC

P/E-Ratio
-22.2
Total Investment
$143 Thousand
Weight
1.0%
Prestige Consumer Healthcare I logo

PBH - Manufacturing

Prestige Consumer Healthcare I

P/E-Ratio
20.2
Total Investment
$142 Thousand
Weight
1.0%